文献速递神经肌肉病认知障碍与痴呆

临床可观察的眼动异常与运动神经元病患者运动及认知特征的关联

Association of Clinically Evident Eye Movement Abnormalities With Motor and Cognitive Features in Patients With Motor Neuron Disorders.
PubMed 文献 · Neurology · 2021-09-09

该研究回顾性分析意大利三组连续住院的肌萎缩侧索硬化(ALS)患者及对照,通过床旁眼动评估发现ALS患者眼动异常(OMAs)频率为10.5%,显著高于认知正常对照(1.6%),与阿尔茨海默病(AD)患者(11.4%)无显著差异;OMAs在两个ALS队列中均与认知功能障碍显著相关,且与认知损害严重程度及ECAS特定域病理评分相关。

要点

  • ALS患者临床可观察的眼动异常发生率为10.5%,显著高于认知正常对照的1.6%。
  • 眼动异常与认知功能障碍显著相关,但与行为改变无关。
  • 球部起病、突出上运动神经元体征及疾病晚期患者眼动异常频率更高。

核心结论

  • ALS患者存在一系列临床可观察的眼动异常,且这些异常与认知而非行为改变显著相关。
  • 眼动异常可能是神经退行性变的标志物,床旁评估可作为检测ALS认知损害快速且高度特异的工具。

研究设计与样本

  • 回顾性评估三个连续住院的意大利ALS患者队列及对照,以评估眼动异常和认知行为改变的频率。
  • ALS人群分为发现队列和复制队列;对照包括认知功能未受损个体和阿尔茨海默病(AD)患者。
  • 共纳入864例ALS患者(发现队列635例,复制队列229例)、798例认知功能未受损对照和171例AD患者。
  • 参与者接受床旁眼动评估以确定眼动异常的存在和模式;认知评估采用标准神经心理学成套测验(发现ALS队列和AD队列)及意大利爱丁堡认知和行为ALS筛查(ECAS)(复制ALS队列)。

主要发现

  • 眼动异常在ALS队列中检出率为10.5%,认知功能未受损对照为1.6%(p = 1.2 × 10-14),AD患者为11.4%(p = NS)。
  • 最常见的眼动缺陷为平滑跟踪和扫视异常。
  • 眼动异常频率在球部起病、突出上运动神经元体征和疾病晚期患者中更高。
  • 认知功能障碍在伴眼动异常的ALS患者中显著更常见(两个ALS队列均p = 1.1 × 10-25)。
  • 眼动异常与认知损害严重程度及ECAS ALS特定域病理评分显著相关;认知损害的ALS患者中35.0%可观察到眼动异常,而AD患者为11.4%(p = 6.4 × 10-7)。

临床怎么用

  • 床旁眼动评估可作为ALS患者认知损害快速且高度特异的检测工具。
  • 对ALS患者,尤其是球部起病、突出上运动神经元体征或疾病晚期者,应关注眼动异常以提示认知损害可能。

局限性

  • 本研究为回顾性评估,可能存在选择偏倚和信息偏倚。
  • 眼动评估为床旁临床观察,未采用视频眼动记录等客观定量方法。
  • 认知评估工具在发现队列和复制队列间不完全一致(标准神经心理学成套测验 vs ECAS)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Although oculomotor abnormalities (OMAs) are not usually considered prominent features of amyotrophic lateral sclerosis (ALS), they may represent potential clinical markers of neurodegeneration, especially when investigated together with cognitive and behavioral alterations. The aim of our study was to identify patterns of clinically evident OMAs in patients with ALS and to correlate such findings with cognitive-behavioral data. METHODS: Three consecutive inpatient cohorts of Italian patients with ALS and controls were retrospectively evaluated to assess the frequency of OMAs and cognitive-behavioral alterations. The ALS population was divided into a discovery cohort and a replication cohort. Controls included a cohort of cognitively impaired individuals and patients with Alzheimer disease (AD). Participants underwent bedside eye movement evaluation to determine the presence and pattern of OMAs. Cognitive assessment was performed with a standard neuropsychological battery (discovery ALS cohort and AD cohort) and the Italian Edinburgh Cognitive and Behavioural ALS Screen (ECAS) (replication ALS cohort). RESULTS: We recruited 864 individuals with ALS (635 discovery, 229 replication), 798 who were cognitively unimpaired and 171 with AD. OMAs were detected in 10.5% of our ALS cohort vs 1.6% of cognitively unimpaired controls (p = 1.2 × 10-14) and 11.4% of patients with AD (p = NS). The most frequent deficits were smooth pursuit and saccadic abnormalities. OMA frequency was higher in patients with bulbar onset, prominent upper motor neuron signs, and advanced disease stages. Cognitive dysfunction was significantly more frequent in patients with OMAs in both ALS cohorts (p = 1.1 × 10-25). Furthermore, OMAs significantly correlated with the severity of cognitive impairment and with pathologic scores at the ECAS ALS-specific domains. Last, OMAs could be observed in 35.0% of cognitively impaired patients with ALS vs 11.4% of patients with AD (p = 6.4 × 10-7), suggesting a possible involvement of frontal oculomotor areas in ALS. CONCLUSION: Patients with ALS showed a range of clinically evident OMAs, and these alterations were significantly correlated with cognitive, but not behavioral, changes. OMAs may be a marker of neurodegeneration, and bedside assessment represents a rapid, highly specific tool for detecting cognitive impairment in ALS.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Poletti B, Solca F, Carelli L, et al. Association of Clinically Evident Eye Movement Abnormalities With Motor and Cognitive Features in Patients With Motor Neuron Disorders. Neurology. 2021. PMID: 34504031. doi:10.1212/WNL.0000000000012774

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。